Batti Jalao

Indian pharma is standing at a crossroads nobody saw coming. The rules of engagement have changed, the tools have changed, and the doctors themselves have changed how they consume information. Most pharma brands haven't noticed yet. The medical rep still matters. But the MR's window in the chamber has shrunk to seconds, not minutes, post-pandemic. Meanwhile, 95% of Indian doctors use WhatsApp every single day. HCPs are consuming bite-sized clinical content between OPD cases,

A patient in Oman needed a knee replacement. He didn't call a hospital. He opened Instagram, watched a 45-second reel of a surgeon in Chennai, checked the Google reviews, asked a question on WhatsApp, and got a response in 12 minutes — complete with a cost estimate and a visa guide. He booked the surgery three weeks later, at one-fifth the cost back home. That's medical tourism in 2026. The hospital that won didn't have the best surgeon. It had the best digital funnel. "The p

Here's a number that should change the way every diagnostic lab in India thinks about marketing. 77% of patients use a search engine before booking a healthcare appointment. And for diagnostic labs specifically, the number is probably higher, because nobody has a family pathologist. People don't have loyalty to a lab. They have loyalty to convenience. "Blood test near me", "CT scan cost in Guwahati", "Thyroid test lab open on Sunday", etc. are a few of the searches that dec